Christine Mikail

President and Chief Financial OfficeratNeurogene· In proxies 2022–2025

Pay in FY2025-18% from the year before · Neurogene stock -9.9% the same year

Christine Mikail was paid $2.8M in FY2025 (Dec), down 18%. Neurogene stock fell 9.9% that year.

Pay$100 in the stock at the end of FY21 → $21

Pay is from the Summary Compensation Table of each Neurogene proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

NGNE
NeurogenePublic company · 4 yr
- President and Chief Financial Officer2022 – Present · 4 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

Pay
Neurogene CFO pay fell 18% to $2.8M. The stock fell 10% in FY2025 (Dec).
DEF 14AApr 16, 2026
Pay
Neurogene CFO pay rose 197% to $3.4M. The stock rose 18% in FY2024 (Dec).
DEF 14AApr 25, 2025
Pay
Neurogene CFO pay rose 85% to $1.1M. The stock rose 90% in FY2023 (Dec).
DEF 14AApr 26, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?